Therapeutic opportunities for caffeine in Alzheimer's disease and other neurodegenerative disorders.
de Mendonça
Alexandre
A
Institute of Molecular Medicine and Faculty of Medicine, University of Lisbon, Portugal.
Cunha
Rodrigo A
RA
D000544:Alzheimer Disease / Q000188:drug therapy*; D002110:Caffeine / Q000627:therapeutic use*; D006801:Humans; D019636:Neurodegenerative Diseases / Q000188:drug therapy*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*
D010726:Phosphodiesterase Inhibitors; D002110:Caffeine